ECR GLOBAL Trademark

Trademark Overview


On Friday, October 14, 2022, a trademark application was filed for ECR GLOBAL with the United States Patent and Trademark Office. The USPTO has given the ECR GLOBAL trademark a serial number of 97632452. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, November 15, 2024. This trademark is owned by Elixir Clinical Research Co.,Ltd.. The ECR GLOBAL trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical assistance; medical clinic services; medical consultations; medical screening; telemedicine services

General Information


Serial Number97632452
Word MarkECR GLOBAL
Filing DateFriday, October 14, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, November 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


Description of MarkThe mark consists of the literal element "ECR Global" in stylized font along with a curved line above the letters "lobal".
Pseudo MarkELIXIR CLINICAL RESEARCH GLOBAL
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical assistance; medical clinic services; medical consultations; medical screening; telemedicine services
NOT AVAILABLE"GLOBAL"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 31, 2022
Primary Code044
First Use Anywhere DateWednesday, March 1, 2023
First Use In Commerce DateWednesday, March 1, 2023

Trademark Owner History


Party NameElixir Clinical Research Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShanghai 201103
CN

Party NameElixir Clinical Research Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 201103
CN

Trademark Events


Event DateEvent Description
Tuesday, October 18, 2022NEW APPLICATION ENTERED
Monday, October 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 1, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, July 29, 2023ASSIGNED TO EXAMINER
Friday, August 4, 2023PRIORITY ACTION WRITTEN
Friday, August 4, 2023PRIORITY ACTION E-MAILED
Friday, August 4, 2023NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, September 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 20, 2024USE AMENDMENT FILED
Monday, May 20, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, June 26, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 1, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, August 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 1, 2024NON-FINAL ACTION E-MAILED
Friday, November 15, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, November 15, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND